InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,274.38
(
0.29%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kevrklar

Send PM Follow Ignore
Followers 25
Posts 158
Boards Moderated 1
Alias Born 04/30/2010

kevrklar

Re: kklar1 post# 93836

Monday, 05/02/2016 6:34:07 PM

Monday, May 02, 2016 6:34:07 PM

Post# of 97239
$TRVN

Trevena Announces Successful End-of-Phase 2 Meeting with FDA and Outlines Phase 3 Program for Oliceridine

- Pivotal efficacy studies to start in 2Q 2016, with topline data expected in 1Q 2017, and NDA filing expected in 2H 2017 -

- Phase 3 program includes comparisons to both placebo and morphine -

- Webcast and call scheduled for today at 5:30 pm EDT -

$HEFF STATION... ALL ABOARD.... LET'S MAKE SOME MONEY

2014 Performance Dec 2013 - Feb 2014

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up